Fund Holdings — Medicxi Ventures Management (Jersey) Ltd

Total Portfolio Value
$427.25M
Total Bought
$22.35M
Total Sold
$27.27M
Net Transaction
-$4.92M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
PHATHOM PHARMACEUTICALS INC(PHAT)7,464,5727,464,572046,80371,58516.75%+24,782
RAPT THERAPEUTICS INC02,794,000+2,794,000022,3525.23%+22,352
AURA BIOSCIENCES INC(AURA)3,039,8923,039,892017,81419,0304.45%+1,216
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
2,869,5652,869,565058,74051,96812.16%-6,772
CENTESSA PHARMACEUTICALS PLC19,963,15719,963,1570287,070262,31661.40%-24,754
RAPT THERAPEUTICS INC22,352,0000-22,352,00027,2690—-27,269
Page 1 of 1
Medicxi Ventures Management (Jersey) Ltd — 13F Holdings — Q2 2025 | TickerTrail